source:
https://www.pharmacynews.com.au/News/Latest-news/TGA-wants-to-ban-popular-anxiety-supplementThe TGA wants to ban or schedule a popular supplement widely touted on social media as a panacea to social anxiety.
Phenibut, which is also known as beta-phenyl GABA (beta-phenyl-gamma-aminobutyric acid), is unscheduled and is marketed to relieve anxiety and depression, improve sleep and enhance cognition.
However, the TGA says there have been case reports of significant toxicity and dependence.
Due to these “serious public health concerns” the delegate is seeking comment on proposals to ban phenibut or making it a schedule 4 drug — with the possibility of a group entry.
Phenibut is a neuropsychotropic drug with anxiolytic and nootropic (cognition enhancing) effects. It acts as a GABA mimetic, primarily at GABAB and to some extent at GABAA receptors, the TGA says.
It is pharmacologically similar to baclofen, which is a schedule 4 medicine.
Phenibut is widely promoted on social media as a treatment for social and work anxiety and to beat insomnia.
However, there are numerous self-reported cases of addiction as well as reports of black-outs and amnesia